ENPP2 and neoplasm: Although T cell abundance was unaffected by ATX inhibition in our models, we note that this may reflect a limitation of the implantable, orthotopic PDAC models used here and that genetically engineered tumor models with slower growth kinetics may reveal additional links between ATX and immune cell abundance in PDAC.